|
OMIM |
Link |
Information gain |
01 |
|
crome syndrome
|
[NCBI]
|
0.00129156
|
|
|
rhabdomyolysis, acute recurrent
|
[NCBI]
|
0.000938013
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.000542647
|
|
|
gout, hprt-related
|
[NCBI]
|
0.00036918
|
|
|
EPO
|
[NCBI]
|
0.000338892
|
|
|
HGF
|
[NCBI]
|
0.000310985
|
|
|
SLE
|
[NCBI]
|
0.000268993
|
|
|
NPPA
|
[NCBI]
|
0.000259402
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
0.000197637
|
|
|
LCN2
|
[NCBI]
|
0.000164272
|
|
|
aHUS
|
[NCBI]
|
0.000154144
|
|
|
PTH
|
[NCBI]
|
0.000153587
|
|
|
EGF
|
[NCBI]
|
0.000149504
|
|
|
TINU
|
[NCBI]
|
0.000144653
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
0.000136165
|
|
|
PCNA
|
[NCBI]
|
0.000122173
|
|
|
TTP
|
[NCBI]
|
0.000115105
|
|
|
CAT
|
[NCBI]
|
0.000113596
|
|
|
glycogen storage disease v
|
[NCBI]
|
0.000104329
|
|
|
SLC22A12
|
[NCBI]
|
0.00010199
|
|
|
LNS
|
[NCBI]
|
8.41844e-05
|
|
|
frasier syndrome
|
[NCBI]
|
7.06778e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
6.99604e-05
|
|
|
HPRT1
|
[NCBI]
|
6.06977e-05
|
|
|
hypouricemia, renal
|
[NCBI]
|
6.02486e-05
|
|
|
denys-drash syndrome
|
[NCBI]
|
5.40011e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
5.11736e-05
|
|
|
RA
|
[NCBI]
|
4.99354e-05
|
|
|
SPINK1
|
[NCBI]
|
4.922e-05
|
|
|
SLSN1
|
[NCBI]
|
4.80553e-05
|
|
|
LIPC
|
[NCBI]
|
4.52507e-05
|
|
|
HNFJ
|
[NCBI]
|
4.17546e-05
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
4.12916e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
3.98495e-05
|
|
|
ATS
|
[NCBI]
|
3.80216e-05
|
|
|
ATP1A1
|
[NCBI]
|
3.79384e-05
|
|
|
ANXA2
|
[NCBI]
|
3.62886e-05
|
|
|
CTNS
|
[NCBI]
|
3.44426e-05
|
|
|
VEGF
|
[NCBI]
|
3.34046e-05
|
|
|
MHS1
|
[NCBI]
|
3.25463e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
3.25463e-05
|
|
|
APRT
|
[NCBI]
|
2.78646e-05
|
|
|
temporal arteritis
|
[NCBI]
|
2.64101e-05
|
|
|
ALB
|
[NCBI]
|
2.61636e-05
|
|
|
PIGR
|
[NCBI]
|
2.41719e-05
|
|
|
XDH
|
[NCBI]
|
2.39978e-05
|
|
|
FMF
|
[NCBI]
|
1.88528e-05
|
|
|
AQP2
|
[NCBI]
|
1.69196e-05
|
|
|
GIP
|
[NCBI]
|
1.66085e-05
|
|
|
WT1
|
[NCBI]
|
1.60179e-05
|
|
|
ACE
|
[NCBI]
|
1.57755e-05
|
|
|
MPO
|
[NCBI]
|
1.51744e-05
|
|
|
TNF
|
[NCBI]
|
1.49311e-05
|
|
|
tyrosinemia, type i
|
[NCBI]
|
1.40472e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.36715e-05
|
|
|
CF
|
[NCBI]
|
1.17791e-05
|
|
|
CDK4
|
[NCBI]
|
9.49915e-06
|
|
|
GIST
|
[NCBI]
|
9.31305e-06
|
|
|
MB
|
[NCBI]
|
8.86684e-06
|
|
|
AVP
|
[NCBI]
|
8.76748e-06
|
|
|
APOE
|
[NCBI]
|
8.43106e-06
|
|
|
PTHLH
|
[NCBI]
|
7.09938e-06
|
|
|
NPY
|
[NCBI]
|
4.81222e-06
|
|
|
SPP1
|
[NCBI]
|
4.79423e-06
|
|
|
EGFR
|
[NCBI]
|
4.77488e-06
|
|
|
ABCC1
|
[NCBI]
|
3.10954e-06
|
|
|
HP
|
[NCBI]
|
2.278e-06
|
|
|
POMC
|
[NCBI]
|
2.09765e-06
|
|
|
PF4
|
[NCBI]
|
1.70199e-06
|
|
|
TLR4
|
[NCBI]
|
1.6486e-06
|
|
|
TF
|
[NCBI]
|
1.37675e-06
|
|
|
F3
|
[NCBI]
|
9.92698e-07
|
|
|
G6PD
|
[NCBI]
|
9.08063e-07
|
|
|
PPARA
|
[NCBI]
|
1.59247e-07
|
|
|
LPL
|
[NCBI]
|
1.29349e-07
|
|